top of page
Search

Peregrine Pharmaceuticals - NEW EBOLA Antiviral Therapy

  • _
  • Oct 17, 2014
  • 1 min read

Peregrine Pharmaceuticals of Tustin , California , USA - is publishing very promising DATA on Phosphatidylserine-targeting monoclonal Antibody- Bravituximab for treatment of EBOLA- Viral Hemorrhagic Fever. It has already been used SAFELY in oncologic therapy in 600 patients - Worldwide

 
 
 

Recent Posts

See All
New Robot Sampling

copy and paste in your browser: http://www.pressreleasepoint.com/new-robot-speeds-sampling-oceans-biogeochemistry-and-health

 
 
 

Comments





bottom of page